跳至主要内容
临床试验/RBR-39ght5
RBR-39ght5进行中(未招募)未知

Efficacy and Durability of Botulinum Toxin in the Treatment of Bruxism - Double Randomized Blind Clinical Study

niversidade Ibirapuera0 个研究点开始时间: 2020年1月21日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
0Y 至 70Y(—)

入选标准

  • Participants of both genders aged 18 to 70 years; participants complaining of clenching, compressing or grinding their teeth for at least 6 months; Masseter and temporal muscle hypertrophy; participants presenting: Headache / chronic orofacial pain, chewing pain, pain on palpation of the chewing and / or facial muscles (middle and lower third of the face).

排除标准

  • Participants with BTX-A or albumin allergy; participants have already had botulinum toxin treatment on these muscles for less than 12 months; pregnant or planning to become pregnant or lactating women; participants who are participating in other research involving other drugs; participants taking drugs that interfere with neuromuscular transmission (Aminoglycosides, Anticholinesterases, etc.) or who are taking antibiotics and corticosteroids; participants who are undergoing orthodontic treatment or using a bite plate.

研究者

发起方
niversidade Ibirapuera

相似试验